Protagenic Therapeutics Statistics
Total Valuation
PTIX has a market cap or net worth of $3.41 million. The enterprise value is $982,184.
Market Cap | 3.41M |
Enterprise Value | 982,184 |
Important Dates
The next estimated earnings date is Monday, August 12, 2024, after market close.
Earnings Date | Aug 12, 2024 |
Ex-Dividend Date | n/a |
Share Statistics
PTIX has 4.45 million shares outstanding. The number of shares has increased by 2.72% in one year.
Shares Outstanding | 4.45M |
Shares Change (YoY) | +2.72% |
Shares Change (QoQ) | +0.94% |
Owned by Insiders (%) | 21.83% |
Owned by Institutions (%) | 17.53% |
Float | 2.83M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | n/a |
Forward PS | n/a |
PB Ratio | 1.60 |
P/FCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 5.53, with zero debt.
Current Ratio | 5.53 |
Quick Ratio | n/a |
Debt / Equity | n/a |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | -77.60 |
Financial Efficiency
Return on equity (ROE) is -156.40% and return on invested capital (ROIC) is -259.14%.
Return on Equity (ROE) | -156.40% |
Return on Assets (ROA) | -124.80% |
Return on Capital (ROIC) | -259.14% |
Revenue Per Employee | n/a |
Profits Per Employee | -$6.01M |
Employee Count | 1 |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -55.22% in the last 52 weeks. The beta is 0.32, so PTIX's price volatility has been lower than the market average.
Beta (5Y) | 0.32 |
52-Week Price Change | -55.22% |
50-Day Moving Average | 1.25 |
200-Day Moving Average | 1.12 |
Relative Strength Index (RSI) | 37.22 |
Average Volume (20 Days) | 11,199 |
Short Selling Information
The latest short interest is 9,122, so 0.20% of the outstanding shares have been sold short.
Short Interest | 9,122 |
Short Previous Month | 14,628 |
Short % of Shares Out | 0.20% |
Short % of Float | 0.32% |
Short Ratio (days to cover) | 0.41 |
Income Statement
Revenue | n/a |
Gross Profit | n/a |
Operating Income | -5.53M |
Pretax Income | -6.01M |
Net Income | -6.01M |
EBITDA | -5.89M |
EBIT | -5.93M |
Earnings Per Share (EPS) | -$1.37 |
Balance Sheet
The company has $2.42 million in cash and no debt, giving a net cash position of $2.42 million or $0.54 per share.
Cash & Cash Equivalents | 2.42M |
Total Debt | n/a |
Net Cash | 2.42M |
Net Cash Per Share | $0.54 |
Equity (Book Value) | 2.13M |
Book Value Per Share | 0.48 |
Working Capital | 2.02M |
Cash Flow
In the last 12 months, operating cash flow was -$4.99 million and capital expenditures -$149,775, giving a free cash flow of -$5.14 million.
Operating Cash Flow | -4.99M |
Capital Expenditures | -149,775 |
Free Cash Flow | -5.14M |
FCF Per Share | -$1.16 |
Margins
Gross Margin | n/a |
Operating Margin | n/a |
Pretax Margin | n/a |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |
Dividends & Yields
PTIX does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -2.72% |
Shareholder Yield | -2.72% |
Earnings Yield | -176.36% |
FCF Yield | -150.94% |
Analyst Forecast
Price Target | n/a |
Price Target Difference | n/a |
Analyst Consensus | n/a |
Analyst Count | n/a |
Revenue Growth Forecast (5Y) | n/a |
EPS Growth Forecast (5Y) | n/a |
Stock Splits
The last stock split was on March 23, 2023. It was a reverse split with a ratio of 1:4.
Last Split Date | Mar 23, 2023 |
Split Type | Reverse |
Split Ratio | 1:4 |
Scores
Altman Z-Score | n/a |
Piotroski F-Score | 1 |